Alfaqawi, F
Lip, P L
Elsherbiny, S
Chavan, R
Mitra, A
Mushtaq, B
Article History
Received: 19 June 2016
Accepted: 20 November 2016
First Online: 20 January 2017
Competing interests
: FA, PLL and RC declare no conflict of interest. SE is an Advisory Board Member of and speaker for Alimera Science, Bayer, Novartis, and Alcon. AM is an Advisory Board Member of Alimera Sciences. BM is an Advisory Board Member of and speaker for Alimera Science, Allergan, Bayer, Novartis, and ORAYA therapeutics.